Given the importance of receptor-mediated signaling in understanding nesfatin-1 function, we first sought to determine its binding sites in BEAS-2B and H1299 cells using FITC-conjugated nesfatin-1, before assessing its effects on lung cancer cells. The gene discussed is NUCB2; the disease is lung carcinoma.